ClinicalTrials.govpublic full text
Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis
idiopathic pulmonary fibrosis, ipf, tipelukast, fibrosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832799
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.